Atalanta Sosnoff Capital, LLC Merck & Co., Inc. Transaction History

Atalanta Sosnoff Capital, LLC

$4.43 Billion
Q2 2024

A detailed history of Atalanta Sosnoff Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Atalanta Sosnoff Capital, LLC holds 584,920 shares of MRK stock, worth $59.2 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

584,920

Previous 587,186 0.39%

Holding current value

$59.2 Million

Previous $77.5 Million 6.54%

% of portfolio

1.63%

Previous 1.79%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $280,530 - $301,287	-2,266 Reduced 0.39%	584,920 $72.4 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $355,913 - $414,718	-3,143 Reduced 0.53%	587,186 $77.5 Million
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $689,639 - $750,493	-6,884 Reduced 1.15%	590,329 $64.4 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $29.7 Million - $33 Million	-288,398 Reduced 32.56%	597,213 $61.5 Million
Q2 2023 Aug 07, 2023	SELL	$108.61 - $118.38 $2.26 Million - $2.46 Million	-20,788 Reduced 2.29%	885,611 $102 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $2.48 Million - $2.77 Million	-24,104 Reduced 2.59%	906,399 $96.4 Million
Q4 2022 May 22, 2023	BUY	$87.44 - $112.11 $2.09 Million - $2.68 Million	23,908 Added 2.64%	930,307 $103 Million
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $10.5 Million - $13.4 Million	-119,910 Reduced 11.42%	930,503 $103 Million
Q3 2022 Oct 12, 2022	SELL	$84.53 - $94.96 $7.66 Million - $8.61 Million	-90,650 Reduced 7.94%	1,050,413 $90.5 Million
Q2 2022 Jul 14, 2022	SELL	$83.49 - $94.64 $1.05 Million - $1.19 Million	-12,525 Reduced 1.09%	1,141,063 $104 Million
Q1 2022 Apr 11, 2022	BUY	$73.51 - $82.4 $19.7 Million - $22.1 Million	267,853 Added 30.24%	1,153,588 $94.7 Million
Q4 2021 Jan 25, 2022	BUY	$72.28 - $90.54 $29 Million - $36.4 Million	401,858 Added 83.05%	885,735 $67.9 Million
Q3 2021 Oct 14, 2021	BUY	$71.68 - $78.83 $34.7 Million - $38.1 Million	483,877 New	483,877 $36.3 Million
Q4 2020 Jan 14, 2021	SELL	$71.77 - $79.65 $37.2 Million - $41.3 Million	-518,457 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$73.18 - $82.95 $554,265 - $628,263	-7,574 Reduced 1.44%	518,457 $43 Million
Q2 2020 Jul 21, 2020	SELL	$70.42 - $80.13 $1.02 Million - $1.16 Million	-14,475 Reduced 2.68%	526,031 $40.7 Million
Q1 2020 Apr 16, 2020	BUY	$63.36 - $87.82 $522,593 - $724,339	8,248 Added 1.55%	540,506 $41.6 Million
Q4 2019 Jan 23, 2020	SELL	$77.58 - $87.54 $453,067 - $511,233	-5,840 Reduced 1.09%	532,258 $48.4 Million
Q3 2019 Oct 15, 2019	BUY	$76.08 - $82.93 $14.7 Million - $16 Million	192,815 Added 55.84%	538,098 $45.3 Million
Q2 2019 Jul 15, 2019	BUY	$69.84 - $81.59 $24.1 Million - $28.2 Million	345,283 New	345,283 $29 Million
Q4 2017 Jan 09, 2018	SELL	$51.62 - $61.64 $1.03 Million - $1.24 Million	-20,045 Closed	0 $0
Q3 2017 Oct 10, 2017	BUY	$58.67 - $63.13 $1.18 Million - $1.27 Million	20,045	20,045 $1.28 Million

Others Institutions Holding MRK

# of Institutions

3,802

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atalanta Sosnoff Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atalanta Sosnoff Capital, LLC with notifications on news.

Account

Atalanta Sosnoff Capital, LLC Merck & Co., Inc. Transaction History